BioSpace News Archive

AgeneBio announced today that it has completed enrollment in a Phase 2B clinical trial evaluating the efficacy of AGB101, a once-a-day investigational medication to treat amnestic Mild Cognitive Impairment due to Alzheimer’s Disease (MCI due to AD).

Mestag Therapeutics (“Mestag”), a breakthrough inflammatory disease and immuno-oncology company, today announced its launch with $11 million seed financing from healthcare investors SV Health Investors and Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”).

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced that the last subject has completed their final visit in the Phase 1b stage of the CB4211 clinical study for nonalcoholic steatohepatitis (NASH) and obesity

Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will report results for its first quarter 2021 ended April 4, 2021, after the market close on May 5, 2021.

The Muscular Dystrophy Association announced the opening of registration for its virtual MDA Summer Camp for children ages 8 to 17 living with muscular dystrophy and related neuromuscular diseases.

Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address acute medical conditions and public health threats, today announced data from a collaborative in vitro study with the Central Virology Laboratory, Ministry of Health, Public Health Services, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel,

endpoint Clinical, the leading global interactive response technology (IRT®) company, announced today the launch of their partnership program, ConnectionPOINT™, the first of its kind in the eClinical technology space.

The Biostasis Research Institute launches by establishing and funding two new research centers at Massachusetts General Hospital and the University of Minnesota aimed at creating human organ banks through the cryogenic storage of organs donated for transplantation.

enlightenVue, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for expanded claims for vascular diagnostic and therapeutic applications of its SurgiVue™ single-use micro-endoscope platform

Battelle is expanding its long-standing commitment to increasing diversity and fostering inclusion within Science, Technology, Engineering and Math (STEM) careers by investing $200,000 over two years to provide students from Bowie State University and Morgan State University research opportunities as they progress from the classroom to employment.